BC020002 Inhibitors
Chemical inhibitors of BC020002 can act through various molecular mechanisms to achieve functional inhibition of this protein. Staurosporine is a potent kinase inhibitor that could impede kinases directly phosphorylating BC020002, thus preventing its activation. Similarly, LY294002 and Wortmannin act as inhibitors of PI3K, a kinase that may be integral to BC020002's function. By blocking PI3K, these inhibitors can halt the signaling processes necessary for BC020002's activity. Rapamycin targets mTOR signaling, potentially disrupting downstream effects if BC020002's function is reliant on the mTOR pathway. Inhibition of mTOR by Rapamycin can therefore result in the functional inhibition of BC020002.
Further, PD98059 and U0126 are inhibitors of MEK, which is a key kinase in the MAPK/ERK pathway. If BC020002 functions downstream of this pathway, its inhibition by PD98059 or U0126 can prevent its proper activity. SB203580, which selectively inhibits p38 MAP kinase, and SP600125, an inhibitor of JNK, can also functionally inhibit BC020002 if it is tied to p38 MAPK or JNK signaling. Imatinib and Gefitinib inhibit specific tyrosine kinases and EGFR tyrosine kinase, respectively, which could lead to BC020002 inhibition if these kinases participate in its regulation. Triciribine targets AKT signaling, which, when inhibited, can limit the activity of BC020002 if AKT is part of its activation mechanism. Lastly, Bisindolylmaleimide I inhibits PKC, and this inhibition could result in the functional inhibition of BC020002 if it is part of the PKC-dependent signaling pathways. Each of these chemicals, by targeting specific kinases or signaling components, can interrupt the pathways necessary for BC020002 to function properly, resulting in its inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits a broad spectrum of protein kinases, which may include kinases directly phosphorylating BC020002, leading to its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of PI3K, and if BC020002 relies on PI3K signaling for its activity, the inhibition of this kinase would result in the functional inhibition of BC020002. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor which could lead to the functional inhibition of BC020002 by halting PI3K-dependent signaling pathways involved in BC020002 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase that may be involved in a signaling pathway with BC020002. Inhibition of mTOR could prevent BC020002 from being involved in downstream signaling, resulting in its functional inhibition. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is upstream in the MAPK/ERK pathway. If BC020002 activity is dependent on this pathway, inhibition by PD98059 would lead to functional inhibition of BC020002. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, another MEK inhibitor, would lead to the functional inhibition of BC020002 by preventing the activation of the MAPK/ERK pathway if BC020002 is a downstream effector in this signaling cascade. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase. The functional inhibition of BC020002 would occur by inhibiting the p38 MAPK pathway if BC020002 requires p38 MAPK signaling for its activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, and if BC020002 operates downstream of JNK signaling, this inhibition would result in the functional inhibition of BC020002. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib selectively inhibits certain tyrosine kinases. If BC020002 is regulated by one of these kinases, then the inhibition by Imatinib would lead to the functional inhibition of BC020002. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase. If BC020002 is part of the EGFR signaling pathway, inhibition by Gefitinib would result in functional inhibition of BC020002. | ||||||